Recent trends in the surgical management of inflammatory bowel disease

Por Roses, Robert E, Rombeau, John L
Publicado em 2008

Radiation as Immunomodulator: Implications for Dendritic Cell-Based Immunotherapy

Por Roses, Robert E., Datta, Jashodeep, Czerniecki, Brian J.
Publicado em 2014

Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas

Por Folkert, Ian W, Hernandez, Paul, Roses, Robert E
Publicado no World J Gastroenterol (2016)

Initiative to reduce bone scans for low-risk prostate cancer patients: A quasi-experimental before-and-after study in a Veterans Affairs hospital

Por Ojerholm, Eric, Van Arsdalen, Keith N., Roses, Robert E., Tripp, Patrick
Publicado no Adv Radiat Oncol (2017)

Neoadjuvant therapy for gastric cancer: current evidence and future directions

Por Newton, Andrew D., Datta, Jashodeep, Loaiza-Bonilla, Arturo, Karakousis, Giorgos C., Roses, Robert E.
Publicado no J Gastrointest Oncol (2015)

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy

Por Datta, Jashodeep, Berk, Erik, Cintolo, Jessica A., Xu, Shuwen, Roses, Robert E., Czerniecki, Brian J.
Publicado no Front Immunol (2015)

Staged management of giant bilateral perinephric adipocytic neoplasms

Por Arriola, Aileen Grace P., Bartlett, Edmund K., Zhang, Paul J., Cooper, Kumarasen, Naji, Ali, Roses, Robert E.
Publicado no Clin Case Rep (2017)

Greater Complexity of Liver Surgery is Not Associated with an Increased Incidence of Liver-Related Complications Except for Bile Leak: An Experience with 2,628 Consecutive Resectio...

Por Zimmitti, Giuseppe, Roses, Robert E., Andreou, Andreas, Shindoh, Junichi, Curley, Steven A., Aloia, Thomas A., Vauthey, Jean-Nicolas
Publicado em 2012

Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy

Por Datta, Jashodeep, Terhune, Julia H., Lowenfeld, Lea, Cintolo, Jessica A., Xu, Shuwen, Roses, Robert E., Czerniecki, Brian J.
Publicado no Yale J Biol Med (2014)

The Palliative Index: Predicting Outcomes of Emergent Surgery in Patients with Cancer

Por Roses, Robert E., Tzeng, Ching-Wei D., Ross, Merrick I., Fournier, Keith F., Abbott, Daniel E., You, Y. Nancy
Publicado em 2014

PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic targe...

Por Gurung, Buddha, Hua, Xianxin, Runske, Melissa, Bennett, Bonita, LiVolsi, Virginia, Roses, Robert, Fraker, Douglas A, Metz, David C
Publicado no Cancer Biol Ther (2014)

HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer

Por Roses, Robert E., Paulson, E. Carter, Sharma, Anupama, Schueller, Jeanne E., Nisenbaum, Harvey, Weinstein, Susan, Fox, Kevin R., Zhang, Paul J., Czerniecki, Brian J.
Publicado em 2009

The Significance of HER-2/neu Receptor Positivity and Immunophenotype in Ductal Carcinoma In-Situ with Early Invasive Disease

Por Harada, Shuko, Mick, Rosemarie, Roses, Robert E., Graves, Holley, Niu, Huilin, Sharma, Anupama, Schueller, Jeanne E., Nisenbaum, Harvey, Czerniecki, Brian J., Zhang, Paul J
Publicado em 2011

Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications

Por Zimmitti, Giuseppe, Vauthey, Jean-Nicolas, Shindoh, Junichi, Tzeng, Ching-Wei D., Roses, Robert E., Ribero, Dario, Capussotti, Lorenzo, Giuliante, Felice, Nuzzo, Gennaro, Aloia, Thomas A.
Publicado em 2013

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction

Por Ecker, Brett L., Taylor, Laura, Zhang, Paul J., Furth, Emma E., Ginsberg, Gregory G., McMillan, Matthew T., Datta, Jashodeep, Czerniecki, Brian J., Roses, Robert E.
Publicado no PLoS One (2016)

Asymptomatic Changes in Cardiac Function Can Occur in DCIS Patients Following Treatment with HER-2/neu Pulsed Dendritic Cell Vaccines

Por Bahl, Susan, Roses, Robert, Sharma, Anupama, Koldovsky, Ursula, Xu, Shuwen, Weinstein, Susan, Nisenbaum, Harvey, Fox, Kevin, Pasha, Theresa, Zhang, Paul, Araujo, Louis, Carver, Joseph, Czerniecki, Brian J
Publicado em 2009

HER-2 Pulsed Dendritic Cell Vaccine Can Eliminate HER-2 Expression and Impact DCIS

Por Sharma, Anupama, Koldovsky, Ursula, Xu, Shuwen, Mick, Rosemarie, Roses, Robert, Fitzpatrick, Elizabeth, Weinstein, Susan, Nisenbaum, Harvey, Levine, Bruce L, Fox, Kevin, Zhang, Paul, Koski, Gary, Czerniecki, Brian J
Publicado em 2012

Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer

Por Datta, Jashodeep, Berk, Erik, Xu, Shuwen, Fitzpatrick, Elizabeth, Rosemblit, Cinthia, Lowenfeld, Lea, Goodman, Noah, Lewis, David A, Zhang, Paul J, Fisher, Carla, Roses, Robert E, DeMichele, Angela, Czerniecki, Brian J
Publicado no Breast Cancer Res (2015)

Association Between Patient Age and Lymph Node Positivity in Thin Melanoma

Por Sinnamon, Andrew J., Neuwirth, Madalyn G., Yalamanchi, Pratyusha, Gimotty, Phyllis, Elder, David E., Xu, Xiaowei, Kelz, Rachel R., Roses, Robert E., Chu, Emily Y., Ming, Michael E., Fraker, Douglas L., Karakousis, Giorgos C.
Publicado no JAMA Dermatol (2017)

Modified Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability...

Por Kaseb, Ahmed O., Shindoh, Junichi, Patt, Yehuda Z., Roses, Robert E., Zimmitti, Giuseppe, Lozano, Richard D., Hassan, Manal M., Hassabo, Hesham M., Curley, Steven A., Aloia, Thomas A., Abbruzzese, James L., Vauthey, Jean-Nicolas
Publicado em 2013